Early use of steroids affects immune cells and impairs immunotherapy efficacy

Early use of steroids affects immune cells and impairs immunotherapy efficacy

Bibliographic Details
Main Authors:	Hiroji Iwata, Takayuki Ueno, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hironobu Sasano, Masakazu Toi
Format:	Article
Language:	English
Published:	Elsevier 2019-02-01
Series:	ESMO Open
Online Access:	https://esmoopen.bmj.com/content/4/1/e000477.full

Similar Items

Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication
by: Hiroji Iwata, et al.
Published: (2019-02-01)

Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TR
by: Takayuki Ueno, et al.
Published: (2019-02-01)

Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor‐positive breast cancer: A multicenter, open‐label, phase II study
by: Nobuaki Sato, et al.
Published: (2019-09-01)

Neoadjuvant endocrine therapy with exemestane followed by response‐guided combination therapy with low‐dose cyclophosphamide in postmenopausal patients with estrogen receptor‐positive breast cancer: A multicenter, open‐label, phase II study
by: Nobuaki Sato, et al.
Published: (2018-07-01)

Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer
by: Masuda Norikazu, et al.
Published: (2010-02-01)

Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study)
by: Eriko Tokunaga, et al.
Published: (2021-08-01)

Personalized Therapy for Breast Cancer: How Long More to be There?
by: Elham Fakhrejahani, et al.
Published: (2014-11-01)

Palbociclib‐letrozole as first‐line treatment for advanced breast cancer: Updated results from a Japanese phase 2 study
by: Masato Takahashi, et al.
Published: (2020-07-01)

Impact of body mass index on breast cancer in accordance with the life-stage of women
by: Reiko eSuzuki, et al.
Published: (2012-10-01)

Prediction of axillary lymph node metastasis in primary breast cancer patients using a decision tree-based model
by: Takada Masahiro, et al.
Published: (2012-06-01)

Characteristic Gene Expression Profiles of Human Fibroblasts and Breast Cancer Cells in a Newly Developed Bilateral Coculture System
by: Takayuki Ueno, et al.
Published: (2015-01-01)

Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR
by: Aogi, K., et al.
Published: (2022)

Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study
by: Hiroyasu Yamashiro, et al.
Published: (2018-07-01)

The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients
by: Sunao Tanaka, et al.
Published: (2017-04-01)

Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)
by: Toshinari Yamashita, et al.
Published: (2020-06-01)

Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD)
by: Toshinari Yamashita, et al.
Published: (2020-05-01)

Estradiol promotes rapid degradation of HER3 in ER-positive breast cancer cell line MCF-7
by: Junko Suga, et al.
Published: (2018-12-01)

Characterization of redox-active cysteine residues of persulfide-responsive transcriptional repressor SqrR
by: Takayuki Shimizu, et al.
Published: (2017-07-01)

Flare hypercalcemia after letrozole in a patient with liver metastasis from breast cancer: a case report
by: Tokita Hiromi, et al.
Published: (2011-10-01)

Experimental study on neutron energy spectra during moderation in the thermal reactor
by: Kuroi, Hideo
Published: (2016)

Detection of the transient conformational fluctuation of blue light sensor protein TePixD and its functional importance
by: Kuroi, Kunisato
Published: (2015)

Tumor Angiogenesis: Pericytes and Maturation Are Not to Be Ignored
by: Elham Fakhrejahani, et al.
Published: (2012-01-01)

A case of Adrenocoricotrophic hormone -independent bilateral adrenocortical macronodular hyperplasia concomitant with primary aldosteronism
by: Mao Tokumoto, et al.
Published: (2017-09-01)

Concentration profiles of ions and particles under hydrodynamic focusing in Y-shaped square microchannel
by: Norikazu Sato, et al.
Published: (2021-01-01)

Animal Models of Autism: An Epigenetic and Environmental Viewpoint
by: Keiko Iwata, et al.
Published: (2010-11-01)

Animal Models of Autism: An Epigenetic and Environmental Viewpoint
by: Keiko Iwata, et al.
Published: (2010-01-01)

Label-free classification of cell types by imaging of cell membrane fluctuations using low-coherent full-field quantitative phase microscopy
by: Yamauchi, Toyohiko, et al.
Published: (2010)

CCNB2 and AURKA overexpression may cause atypical mitosis in Japanese cortisol-producing adrenocortical carcinoma with TP53 somatic variant.
by: Akira Ikeya, et al.
Published: (2020-01-01)

In-situ visualization library for Yin-Yang grid simulations
by: Nobuaki Ohno, et al.
Published: (2021-08-01)

ORGANIC SYNTHETIC REACTIONS USING CARBONYLFERRATES
by: Yamashita, Masakazu
Published: (2017)

Adrenal and Hepatic Venous Sampling in a Case of Aldosterone-Producing Adrenocortical Carcinoma with Hepatic Metastasis
by: Toru Sugiyama, et al.
Published: (2021-01-01)

Taxonomic Reassessment of the Izumo Lineage of <i>Hynobius utsunomiyaorum</i>: Description of a New Species from Chugoku, Japan
by: Hirotaka Sugawara, et al.
Published: (2021-07-01)

Mental Health Problems and Their Association With Internet Use in Medical Residents
by: Tsukasa Ueno, et al.
Published: (2020-10-01)

Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from the MONARCH 2 trial
by: Patrick Neven, et al.
Published: (2021-08-01)

Changes in Optical Coherence Tomography Findings in Acute Zonal Occult Outer Retinopathy
by: Shinji Makino, et al.
Published: (2013-09-01)

Acute Macular Neuroretinopathy in a 15-Year-Old Boy: Optical Coherence Tomography and Visual Acuity Findings
by: Shinji Makino, et al.
Published: (2014-01-01)

Rare and Unusual Choroidal Abnormalities in a Patient with Systemic Lupus Erythematosus
by: Shinji Makino, et al.
Published: (2013-08-01)

Optical Coherence Tomography Imaging of Choroidal Abnormalities in Neurofibromatosis Type 1
by: Shinji Makino, et al.
Published: (2013-01-01)

Observational Study of Umbral Dots. Manifestation of Magnetoconvection in a Solar Sunspot
by: Masuda(Watanabe), Hiroko
Published: (2012)

Estrogen-Related Factors in the Frontal Lobe of Alzheimer’s Disease Patients and Importance of Body Mass Index
by: Naoko Honma, et al.
Published: (2017-04-01)